Waters Gains FDA Clearance for Flow Cytometry Tests for Blood CancersZacks Investment Research • Wednesday
Waters Achieves FDA 510(k) Clearance for Ready-to-Use Flow Cytometry Clinical Tests for Leukemia and LymphomaPRNewsWire • Tuesday
Waters Q3 Earnings & Revenues Beat Estimates, 2026 Guidance RaisedZacks Investment Research • 11/03/26
Waters (WAT) Q3 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 11/03/26
Waters Acquires MOBILion Systems, Bringing Advanced Ion-Mobility Separation to its Mass Spectrometry Portfolio with the Speed and Resolution AI Workflows Require for Proteomics Biomarker DiscoveryPRNewsWire • 11/03/26
Waters Launches AI-Powered Peak Integration Expanding its Suite of Premium AI Subscription Capabilities for Empower SoftwarePRNewsWire • 10/28/26
Waters & Labcorp Expand Access to FDA-Approved HPV Screening TestsZacks Investment Research • 10/27/26
Waters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved HPV Testing Option Beginning in Late 2026PRNewsWire • 10/23/26
Waters Corporation and Quest Diagnostics Help Close Cervical Cancer Screening Gap Bringing Nationwide Access to the Most Comprehensive FDA-Cleared At-Home HPV Screening OptionPRNewsWire • 10/20/26
Waters Launches AI Link, Advancing AI-Enabled LC-MS Workflows from Research to ReleasePRNewsWire • 10/13/26